Safety Evaluation of Cimetidine: Report at the Termination of a Seven-year Study in Dogs

Abstract

Cimetidine in tablet form was administered orally daily to eight male and four female beagle dogs at a dose level of 144 mg kg^-1 for 385 weeks. Four male and two female control dogs received placebo tablets. Treatment with cimetidine did not affect the clinical condition of the dogs, but was associated with a slightly less rapid weight gain. Five dogs (two cimetidine-treated and three controls) were killed during the course of the study for reasons not related to treatment. Treatment with cimetidine did not affect haematological, clinical chemical, urinalysis or electrocardiographic parameters. Multiple biopsies of gastric mucosa taken at intervals of approximately six months from Week 177 to Week 363 showed no change which could be attributed to treatment with cimetidine. There were no toxic effects on the gastric mucosa of any dog. At necropsy no treatment-related findings were reported except for reduction in prostate size in 6/8 males receiving cimetidine. This was expected in view of previous experience with cimetidine.

Get full access to this article

View all access options for this article.

References

Black J W. , Duncan Wam , Durant GJ , Ganellin CR & Parsons ME (1972). Definition of antagonism of histamine H2 receptors . Nature (Lond.), 236, 385.

Brimblecombe RW , Leslie GB & Walker TF (1985 ). Toxicology of cimetidine. Human Toxicol., 4, 13-25.

Crean GP , Leslie GB & Roe Fjc (1979). Cimetidine and gastric cancer; negative studies in dogs. Lancet, 797-798.

Crean GP , Leslie GB , Walker TF , Whitehead SM & Roe Fjc. (1981). Safety evaluation of cimetidine: 54 month interim report on long-term study in dogs. J. appl. Toxicol., 1, 159-164.

Crean GP , Morson BC , Leslie GB & Roe Fjc (1981). Cimetidine: further evidence of non-carcinogenicity in dogs. New England. J. Med., 304, 672.

Ainge G. & Poynter D. (1981). H2 receptor antagonists: ultrastructure of canine parietal cells after long term treatment with ranitidine. Scand. J. Gastroenterology, 16 (suppl. 70), 143.

Stachura J. , Konturek SJ , Cieszkowsky M. , Dabros W. , Zakrewska J. & Konturek J. (1983). Comparison of the effect of omeprazole - a substituted benzimidazole - and ranitidine - a potent H2-receptor antagonist - on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells. Hepatogastroenterol., 30, 205-210.

Elder JB , Ganguli PC & Gillespie IF (1979). Cimetidine and gastric cancer. Lancet, i, 1005-1006.

Sigimura T. & Fujimura S. (1967). Tumour production in glandular stomachs of rat by N-methyl-N'-nitro-N-nitrosoguanidine. Nature ( Lond.), 216, 943-944.